Literature DB >> 27570425

Herbal medicines and nonalcoholic fatty liver disease.

Hong Yao1, Yu-Jie Qiao1, Ya-Li Zhao1, Xu-Feng Tao1, Li-Na Xu1, Lian-Hong Yin1, Yan Qi1, Jin-Yong Peng1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD), which is characterized by excessive fat accumulation in the liver of patients who consume little or no alcohol, becomes increasingly common with rapid economic development. Long-term excess fat accumulation leads to NAFLD and represents a global health problem with no effective therapeutic approach. NAFLD is considered to be a series of complex, multifaceted pathological processes involving oxidative stress, inflammation, apoptosis, and metabolism. Over the past decades, herbal medicines have garnered growing attention as potential therapeutic agents to prevent and treat NAFLD, due to their high efficacy and low risk of side effects. In this review, we evaluate the use of herbal medicines (including traditional Chinese herbal formulas, crude extracts from medicinal plants, and pure natural products) to treat NAFLD. These herbal medicines are natural resources that can inform innovative drug research and the development of treatments for NAFLD in the future.

Entities:  

Keywords:  Herbal medicines; Natural product; Nonalcoholic fatty liver disease; Review; Traditional Chinese medicines

Mesh:

Substances:

Year:  2016        PMID: 27570425      PMCID: PMC4974587          DOI: 10.3748/wjg.v22.i30.6890

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  170 in total

1.  Synthesis of monomethylated dioscin derivatives and their antitumor activities.

Authors:  Ming Li; Xiuwen Han; Biao Yu
Journal:  Carbohydr Res       Date:  2003-01-20       Impact factor: 2.104

2.  Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.

Authors:  Goiuri Alberdi; Víctor M Rodríguez; M Teresa Macarulla; Jonatan Miranda; Itziar Churruca; María P Portillo
Journal:  Nutrition       Date:  2012-12-28       Impact factor: 4.008

3.  Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet.

Authors:  Xiaojun Liu; Yong Gao; Meixia Li; Chao Geng; Haifeng Xu; Yaoguo Yang; Yongjun Guo; Tao Jiao; Fude Fang; Yongsheng Chang
Journal:  J Hepatol       Date:  2015-05-27       Impact factor: 25.083

Review 4.  Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.

Authors:  Min-Hsiung Pan; Ching-Shu Lai; Mei-Ling Tsai; Chi-Tang Ho
Journal:  Mol Nutr Food Res       Date:  2013-12-03       Impact factor: 5.914

5.  Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice.

Authors:  Mingming Gao; Yongjie Ma; Dexi Liu
Journal:  Pharm Res       Date:  2013-06-20       Impact factor: 4.200

6.  Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.

Authors:  Byeong Tak Jeon; Eun Ae Jeong; Hyun Joo Shin; Younghyurk Lee; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Diabetes       Date:  2012-02-23       Impact factor: 9.461

7.  Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1.

Authors:  Chu-Sook Kim; Yoonhee Kwon; Suck-Young Choe; Sun-Myung Hong; Hoon Yoo; Tsuyoshi Goto; Teruo Kawada; Hye-Seon Choi; Yeonsoo Joe; Hun Taeg Chung; Rina Yu
Journal:  Nutr Metab (Lond)       Date:  2015-10-06       Impact factor: 4.169

8.  Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.

Authors:  Aline B Santamarina; Juliana L Oliveira; Fernanda P Silva; June Carnier; Laís V Mennitti; Aline A Santana; Gabriel H I de Souza; Eliane B Ribeiro; Cláudia M Oller do Nascimento; Fábio S Lira; Lila M Oyama
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

9.  Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.

Authors:  Hiu Yee Kwan; Xuyan Niu; Wenlin Dai; Tiejun Tong; Xiaojuan Chao; Tao Su; Chi Leung Chan; Kim Chung Lee; Xiuqiong Fu; Hua Yi; Hua Yu; Ting Li; Anfernee Kai Wing Tse; Wang Fun Fong; Si-Yuan Pan; Aiping Lu; Zhi-Ling Yu
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

10.  Effect of pioglitazone, quercetin and hydroxy citric acid on extracellular matrix components in experimentally induced non-alcoholic steatohepatitis.

Authors:  Surapaneni Krishna Mohan; Vishnu Priya Veeraraghavan; Mallika Jainu
Journal:  Iran J Basic Med Sci       Date:  2015-08       Impact factor: 2.699

View more
  32 in total

Review 1.  Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.

Authors:  Usman Sabir; Hafiz Muhammad Irfan; Ihtisham Umer; Zahid Rasul Niazi; Hafiz Muhammad Mazhar Asjad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-31       Impact factor: 3.000

Review 2.  Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Manuel Suárez; Noemí Boqué; Josep M Del Bas; Jordi Mayneris-Perxachs; Lluís Arola; Antoni Caimari
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

3.  Medicinal Herbs and Their Active Compounds for Fatty Liver Diseases.

Authors:  Chang Gue Son; Zhang Wei; H Balaji Raghavendran; Jing-Hua Wang; Elzbieta Janda
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-07       Impact factor: 2.629

4.  Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.

Authors:  Daniel Cabrera; Alexander Wree; Davide Povero; Nancy Solís; Alejandra Hernandez; Margarita Pizarro; Han Moshage; Javiera Torres; Ariel E Feldstein; Claudio Cabello-Verrugio; Enrique Brandan; Francisco Barrera; Juan Pablo Arab; Marco Arrese
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

5.  Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.

Authors:  Qi Huang; Ting Wang; Liu Yang; He-Yao Wang
Journal:  Int J Mol Sci       Date:  2017-05-19       Impact factor: 5.923

Review 6.  Chinese Herbal Medicines Attenuate Acute Pancreatitis: Pharmacological Activities and Mechanisms.

Authors:  Hong Xiang; Qingkai Zhang; Bing Qi; Xufeng Tao; Shilin Xia; Huiyi Song; Jialin Qu; Dong Shang
Journal:  Front Pharmacol       Date:  2017-04-25       Impact factor: 5.810

7.  PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway.

Authors:  Yu Liu; Fei Cheng; Yuxuan Luo; Zhu Zhan; Peng Hu; Hong Ren; Huadong Tang; Mingli Peng
Journal:  Biomed Res Int       Date:  2017-07-09       Impact factor: 3.411

8.  Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice.

Authors:  Yi Chen; Zhaohui Jiang; Jinzhuan Xu; Jiyuan Zhang; Runbin Sun; Jia Zhou; Yuan Lu; Zipeng Gong; Jing Huang; Xiangchun Shen; Qianming Du; Jianqing Peng
Journal:  J Nanobiotechnology       Date:  2021-08-04       Impact factor: 10.435

9.  Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.

Authors:  Kangkang Yin; Xiao Zhou; Wei Jiang; Linlin Wang; Ziwei Dai; Biao Tang
Journal:  Dis Markers       Date:  2021-06-18       Impact factor: 3.434

10.  Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease.

Authors:  Francesca M Trovato; Giuseppe Fabio Martines; Daniela Brischetto; Guglielmo Trovato; Daniela Catalano
Journal:  World J Hepatol       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.